Plain-English translation of NCT06986278 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcranial direct current stimulation (tDCS) paired with treadmill-based walking training in people with multiple sclerosis. tDCS is a non-invasive technique that uses a small electrical current applied to the scalp to help improve brain activity. The study wants to see whether this treatment, when combined with structured walking practice, can help you walk better and keep your balance more steadily.
Many people with multiple sclerosis struggle with walking and balance problems that affect their daily life. Early research suggests that this type of brain stimulation might enhance the brain's ability to learn and adapt during walking training, potentially leading to better outcomes than training alone.
You likely qualify if…
You likely don't qualify if…
You will attend sessions where you receive either real or sham (placebo) brain stimulation for 20 minutes while wearing electrodes on your head and shoulder. During this same 20 minutes, you'll walk on a treadmill with a safety harness that supports part of your body weight to reduce fall risk and allow you to focus on your gait. The study uses a triple-blind design, meaning neither you, the researchers, nor the people analyzing the results will know whether you're receiving real or placebo stimulation—this helps ensure fair results. You'll be assessed on your walking ability, balance, and fatigue levels throughout the trial.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Spain